Yoshiro Kato

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Norihiro Nishimoto, Yuzuru Kanakura, Katsuyuki Aozasa et al. · Blood · 2005 · 745 citations · Full text

Case of ketoacidosis by a sodium‐glucose cotransporter 2 inhibitor in a diabetic patient with a low‐carbohydrate diet

Tomohide Hayami, Yoshiro Kato, Hideki Kamiya et al. · Journal of Diabetes Investigation · 2015 · 115 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +11

Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia

M Nitta, Yoshiro Kato, A Strife et al. · Blood · 1985 · 89 citations · Full text

Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes

Tsutomu Yamada, Nobuaki Ozaki, Yoshiro Kato et al. · Biochemical and Biophysical Research Communications · 2006 · 62 citations

Metabolic Syndrome, Molecular Physiology, Diabetes +7

Omega‐3 polyunsaturated fatty acids exert anti‐oxidant effects through the nuclear factor (erythroid‐derived 2)‐related factor 2 pathway in immortalized mouse Schwann cells

Yasuaki Tatsumi, Ayako Kato, Kazunori Sango et al. · Journal of Diabetes Investigation · 2018 · 57 citations · Full text